세계의 혈액백 시장 보고서 : 제품 유형, 용도, 최종 사용자, 재료, 용량 및 지역별(2024-2032년)

The global blood bags market size reached US$ 289.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 579.0 Million by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. The market is experiencing moderate growth driven by the rising demand for blood transfusions, various technological advancements, the expanding healthcare infrastructure in emerging markets, stringent regulatory compliance, and the growing awareness about blood donation.

Blood Bags Market Analysis:

Market Growth and Size: The market is witnessing moderate growth, driven by the increasing demand for blood transfusions due to surgeries, accidents, and medical conditions.

Technological Advancements: Technological advancements in the manufacturing of blood bags have enhanced their safety and usability, reduced the risk of contamination and improved storage conditions. Innovations include the use of RFID tracking for blood bag management and the development of advanced materials to extend the shelf life of stored blood.

Industry Applications: Blood bags are primarily used in hospitals, blood banks, and healthcare facilities for collecting, storing, and transporting blood and its components. They play a crucial role in supporting medical procedures, such as surgeries, trauma care, and cancer treatments.

Geographical Trends: Geographically, the demand for blood bags is significant in both developed and developing regions. However, emerging economies are experiencing a higher growth rate due to improving healthcare infrastructure. North America and Europe remain key markets, but Asia-Pacific is expected to show substantial growth in the coming years.

Competitive Landscape: The global blood bags market is highly competitive, with several established players dominating the industry. Key manufacturers include Terumo Corporation, Fresenius SE & Co. KGaA, and Macopharma, among others, who continuously strive to innovate and maintain quality standards.

Challenges and Opportunities: Challenges in the blood bags market include stringent regulatory requirements, which can increase production costs, and the need for a stable supply of blood. Opportunities lie in expanding into emerging markets, developing eco-friendly blood bag materials, and investing in research to reduce the risk of contamination during storage.

Future Outlook: The future of the global blood bags market appears promising, with the demand for blood and blood components expected to rise due to an aging population and increasing medical procedures. Market players should focus on sustainability, technological innovation, and strategic partnerships to remain competitive in this evolving landscape.

Blood Bags Market Trends:

Increasing Demand for Blood Transfusions

The primary driver of the global blood bags market is the rising demand for blood transfusions. As healthcare systems worldwide continue to advance, there is a growing need for blood and blood components to support medical procedures such as surgeries, trauma care, and cancer treatments. Moreover, the increasing prevalence of chronic diseases, including cancer and blood disorders, contributes to the demand for blood products. The steady increase in the aging population is also a significant factor. Older individuals often require blood transfusions for various medical conditions, further propelling the demand for blood bags. This sustained demand ensures a stable market for blood bag manufacturers.

Significant Technological Advancements in Blood Bag Manufacturing

Technological advancements have significantly improved the quality and safety of blood bags. Innovations in materials, such as the use of PVC-free and DEHP-free materials, reduce the risk of contamination and ensure the integrity of stored blood components. RFID tracking systems enhance inventory management in blood banks, enhancing efficiency and traceability. Furthermore, the development of specialized blood bags for specific purposes, such as platelet-rich plasma (PRP) bags and leukocyte reduction filters, has expanded the product range, meeting the evolving needs of healthcare providers. These technological advancements drive market growth and enhance patient safety.

Growing Healthcare Infrastructure in Emerging Markets

Emerging economies are witnessing a significant expansion of their healthcare infrastructure, leading to increased accessibility to medical facilities and treatments. This expansion correlates with a rising demand for blood bags in these regions. As healthcare services become more accessible and advanced, the need for blood bags for surgeries, childbirth, and emergency care rises. The Asia-Pacific region, in particular, is experiencing substantial growth in its blood bags market due to its expanding healthcare sector. This trend is expected to continue as these regions continue to invest in improving their healthcare systems.

Regulatory Compliance and Quality Assurance

Stringent regulatory requirements and quality standards drive advancements in blood bag manufacturing. Regulatory bodies worldwide impose strict guidelines to ensure the safety and quality of blood products. Compliance with these regulations necessitates continuous research and development efforts by manufacturers to improve product design and manufacturing processes. Adherence to these standards ensures patient safety and also maintains the reputation and credibility of blood bag manufacturers. Companies that can consistently meet and exceed regulatory requirements gain a competitive edge in the market.

Rising Awareness and Blood Donation Campaigns

Public awareness campaigns and initiatives to encourage blood donation have played a crucial role in sustaining the blood bags market. These campaigns educate the public about the importance of donating blood and its life-saving potential. As awareness increases, more individuals are likely to donate blood voluntarily, contributing to a steady supply of blood and the need for blood bags. Moreover, during emergencies, natural disasters, and pandemics, there is often a rise in blood donation drives, further emphasizing the significance of a robust blood bags market to handle these situations efficiently.

Blood Bags Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application, end user, material, and capacity.

Breakup by Product Type:

Single Blood Bag

Double Blood Bag

Triple Blood Bag

Quadruple Blood Bag

Penta Blood Bag

Single blood bag accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes single blood bag, double blood bag, triple blood bag, quadruple blood bag, and penta blood bag. According to the report, single blood bags represented the largest segment.

Breakup by Application:

Collection Blood Bag

Transfer Blood Bag

Collection blood bag holds the largest share in the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes collection blood bag and transfer blood bag. According to the report, collection blood bag accounted for the largest market share.

Breakup by End User:

Hospitals

Clinics

Ambulatory Surgical Centers

Blood Banks

Others

Hospitals represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user This includes hospitals, clinics, ambulatory surgical centers, blood banks and others. According to the report, hospitals represented the largest segment.

Breakup by Material:

Poly Vinyl Chloride Blood Bag

Polyethylene Terephthalate Blood Bag

Others

Poly vinyl chloride blood bag represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the material. This includes poly vinyl chloride blood bag, polyethylene terephthalate blood bag, and others. According to the report, poly vinyl chloride blood bags represented the largest segment.

Breakup by Capacity:

100ml Blood Bag

150ml Blood Bag

250ml Blood Bag

300ml Blood Bag

350ml Blood Bag

400ml Blood Bag

450ml Blood Bag

500ml Blood Bag

300ml blood bag represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the capacity. This includes 100ml blood bag, 150ml blood bag, 250ml blood bag, 300ml blood bag, 350ml blood bag, 400ml blood bag, 450ml blood bag, and 500ml blood bag. According to the report, 300 ml blood bag represented the largest segment.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Turkey

South Africa

Saudi Arabia

UAE

Others

North America leads the market, accounting for the largest blood bags market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa (Turkey, South Africa, Saudi Arabia, UAE, and others). According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AdvaCare Pharma

BL Life Sciences Pvt. Ltd

Demophorius Healthcare Ltd.

Fresenius SE & Co. KGaA

Grifols S.A.

Haemonetics Corporation

HLL Lifecare Limited

Innvol Medical India Limited

JMS Co. Ltd.

Kawasumi Laboratories Inc.

Maco Pharma International GmbH

Mitra Industries Pvt. Ltd.

Neomedic Limited

Poly Medicure Ltd.

Span Healthcare Private Limited

Suru International Private Ltd.

Teleflex Incorporated

Terumo Corporation

The Metric Company

Troge Medical GmbH

Key Questions Answered in This Report

• 1. What was the size of the global blood bags market in 2023?
• 2. What is the expected growth rate of the global blood bags market during 2024-2032?
• 3. What are the key factors driving the global blood bags market?
• 4. What has been the impact of COVID-19 on the global blood bags market?
• 5. What is the breakup of the global blood bags market based on the product type?
• 6. What is the breakup of the global blood bags market based on the application?
• 7. What is the breakup of the global blood bags market based on the end user?
• 8. What is the breakup of the global blood bags market based on the material?
• 9. What is the breakup of the global blood bags market based on the capacity?
• 10. What are the key regions in the global blood bags market?
• 11. Who are the key players/companies in the global blood bags market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Blood Bags Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Single Blood Bag
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Double Blood Bag
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Triple Blood Bag
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Quadruple Blood Bag
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Penta Blood Bag
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Collection Blood Bag
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Transfer Blood Bag
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Blood Banks
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Material

• 9.1 Poly Vinyl Chloride Blood Bag
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Polyethylene Terephthalate Blood Bag
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Capacity

• 10.1 100ml Blood Bag
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 150ml Blood Bag
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 250ml Blood Bag
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 300ml Blood Bag
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 350ml Blood Bag
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast
• 10.6 400ml Blood Bag
  • 10.6.1 Market Trends
  • 10.6.2 Market Forecast
• 10.7 450ml Blood Bag
  • 10.7.1 Market Trends
  • 10.7.2 Market Forecast
• 10.8 500ml Blood Bag
  • 10.8.1 Market Trends
  • 10.8.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Germany
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 France
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 United Kingdom
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 Italy
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Spain
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Russia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Asia Pacific
  • 11.3.1 China
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 Japan
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 India
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 South Korea
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Australia
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Singapore
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Argentina
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
  • 11.4.4 Others
    • 11.4.4.1 Market Trends
    • 11.4.4.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Turkey
    • 11.5.1.1 Market Trends
    • 11.5.1.2 Market Forecast
  • 11.5.2 South Africa
    • 11.5.2.1 Market Trends
    • 11.5.2.2 Market Forecast
  • 11.5.3 Saudi Arabia
    • 11.5.3.1 Market Trends
    • 11.5.3.2 Market Forecast
  • 11.5.4 UAE
    • 11.5.4.1 Market Trends
    • 11.5.4.2 Market Forecast
  • 11.5.5 Others
    • 11.5.5.1 Market Trends
    • 11.5.5.2 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

• 15.1 Key Price Indicators
• 15.2 Price Structure
• 15.3 Price Trends

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 AdvaCare Pharma
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 BL Life Sciences Pvt. Ltd
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 Demophorius Healthcare Ltd.
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 Fresenius SE & Co. KGaA
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Grifols S.A.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Haemonetics Corporation
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 HLL Lifecare Limited
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Innvol Medical India Limited
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 JMS Co. Ltd.
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
  • 16.3.10 Kawasumi Laboratories Inc.
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
  • 16.3.11 Maco Pharma International GmbH
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Mitra Industries Pvt. Ltd.
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
  • 16.3.13 Neomedic Limited
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio
  • 16.3.14 Poly Medicure Ltd.
    • 16.3.14.1 Company Overview
    • 16.3.14.2 Product Portfolio
  • 16.3.15 Span Healthcare Private Limited
    • 16.3.15.1 Company Overview
    • 16.3.15.2 Product Portfolio
  • 16.3.16 Suru International Private Ltd.
    • 16.3.16.1 Company Overview
    • 16.3.16.2 Product Portfolio
  • 16.3.17 Teleflex Incorporated
    • 16.3.17.1 Company Overview
    • 16.3.17.2 Product Portfolio
    • 16.3.17.3 Financials
    • 16.3.17.4 SWOT Analysis
  • 16.3.18 Terumo Corporation
    • 16.3.18.1 Company Overview
    • 16.3.18.2 Product Portfolio
    • 16.3.18.3 Financials
    • 16.3.18.4 SWOT Analysis
  • 16.3.19 The Metric Company
    • 16.3.19.1 Company Overview
    • 16.3.19.2 Product Portfolio
  • 16.3.20 Troge Medical GmbH
    • 16.3.20.1 Company Overview
    • 16.3.20.2 Product Portfolio